Alzheimer Patients and the Snoezelen Program
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
To determine the connection between Social Withdrawal and Sensory Deprivation in elderly clients with Alzheimer's Type Dementia (i.e. how providing sensory stimulation might reduce social withdrawal).
| Condition | Intervention | Phase |
|---|---|---|
|
Dementia |
Other: Snoezelen Room Other: Control |
Phase 1 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | The Connection Between Sensory Deprivation and Social Withdrawal in Clients of a Long Term Care Facility Living With Alzheimer's Disease and the Effects of a Snoezelen Program. |
- To evaluate improvement of the residents who are given Snoezelen sessions. [ Time Frame: 12 weeks ] [ Designated as safety issue: No ]
| Enrollment: | 18 |
| Study Start Date: | September 2005 |
| Study Completion Date: | December 2006 |
| Primary Completion Date: | December 2006 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: 1
Subject receives Snoezelen sessions once per week.
|
Other: Snoezelen Room
Session in a Snoezelen room once per week for 12 weeks
|
|
Active Comparator: 2
Subject receives Snoezelen sessions three times per week.
|
Other: Snoezelen Room
Session in a Snoezelen room three times per week for 12 weeks
|
|
3
Subject receives no sessions per week.
|
Other: Control
Receive no sessions in a Snoezelen Room.
|
Detailed Description:
The Snoezelen concept or program was originally thought up in Holland and comes from two Dutch words meaning to "sniff and doze". It was first introduced in the Netherlands in the 1970's. The first room was introduced in Snoezelen examines how a group of people react to an area that is private, relaxed and one that they trust. This program will bring out one's sense of taste, touch, smell, sight and hearing just by being in a specially designed room. Trust and relaxation will be looked at by those people with developmental disabilities (those that learn at a slower rate). Snoezelen originated with the belief that everyone needs nerve pulses (senses).
Inside a Snoezelen room you will find, dimmed lights, a relaxed atmosphere and pleasant surroundings, soothing sounds, intriguing aromas, tasty puddings, candies, interesting light effects (fiber optic light spray), comfortable seating, opportunities for interaction and engagement, sense of control over environment, tactile objects (awareness box), bubble tube, solar projector wheel, water fountain, massage pillow, massage tube, tranquility and solitude. The Snoezelen room is an environment in which the primary senses (see, hear, taste, touch) are stimulated all to create an environment that is both relaxing and stimulating. The benefits of Snoezelen change per person but may include some of the following:
- Increased resident and caregiver communication
- Increased awareness and understanding of the environment
The Snoezelen idea: client-controlled, safe comfortable atmosphere and freedom from pressure.
Sensory Deprivation (loss) The average person touches 300 different surfaces every 30 minutes. The average person with a profound disability will likely touch 1-5 surfaces in the same time frame.
Eligibility| Ages Eligible for Study: | 65 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Residents living at Rideaucrest Home (Long Term Care Facility in Kingston, Ontario);
- Residents having a Mini Mental State Exam with a score of 15 to 27 reflecting mild to moderate dementia;
- Male or female over 65 years of age;
- Resident who are able to leave the terrace;
- Resident who are not actively participating in Life Enrichment Programs;
- Able to provide informed written and signed consent by resident or substitute decision maker.
Exclusion Criteria:
- Suffering from severe life threatening illness with a reasonable expectation of death within the next six month;
- Severe mental disorder in the opinion of the investigator (i.e. bipolar, schizophrenia);
- No recent change in medication(s) during the past four weeks prior to the project;
- Other non-Alzheimer-Type Dementia;
- Residents who suffer from Epilepsy.
Contacts and Locations More Information
No publications provided
| Responsible Party: | Dr. Roumen V. Milev, Queen's University |
| ClinicalTrials.gov Identifier: | NCT00548951 History of Changes |
| Other Study ID Numbers: | PSIY-205-05 |
| Study First Received: | September 12, 2005 |
| Last Updated: | August 19, 2008 |
| Health Authority: | Canada: Health Canada |
Keywords provided by Queen's University:
|
Dementia |
Additional relevant MeSH terms:
|
Dementia Brain Diseases Central Nervous System Diseases |
Nervous System Diseases Delirium, Dementia, Amnestic, Cognitive Disorders Mental Disorders |
ClinicalTrials.gov processed this record on May 22, 2013